Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 31, 2022npj VaccinesOpen Access

Toxoplasmosis vaccines: what we have and where to go?

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYizhuo ZhangDLDan LiSLShaohong Lu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2022) studied this question.

synapsesocial.com/papers/69df332ede200760a8614a3ehttps://doi.org/10.1038/s41541-022-00563-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice2018 · 521 citations
  2. 2Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice2017 · 12 citations
  3. 3Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection2019 · 141 citations